OTTAWA (CP) - Defence officials have signed a $2.9-million deal with a U.S. firm to develop an anti-anthrax inhaler that could be available for civilian as well as military use.
Aradigm Corp. of California will spend the next few years developing and testing a puffer to counter the effects of anthrax and other biological warfare agents. The inhaler, conceived by Defence Department researchers, will contain the powerful antibiotic ciproflaxacin. "The initial target population was military use," said Maj. Don Van Loon, a bio-science officer.
Excerpted
http://www.canada.com/news/national/story.html?id=362b5894-c659-4688-af73-51a9135062f5
Kelly 'could not have died' from knife wound, paramedics claim
The Scotsman
Monday, Dec. 13, 2004
DAN MCDOUGALL
Key points
• Paramedics believe wounds unlikely as cause of death due to lack of blood
• Medical situation complicated by opiate drugs and blood condition in victim
• Thames Valley Police have no intention of re-opening the case
Key quote I just think it is incredibly unlikely that he died from the wrist wound we saw. There just wasn’t a lot of blood. When someone cuts an artery, whether accidentally or intentionally, the blood pumps everywhere." - VANESSA HUNT, PARAMEDIC
Story in full POLICE have rejected calls to re-open the inquiry into the death of Dr David Kelly, the government weapons expert, after two paramedics who found him at the scene of his death said he could not have died from self-inflicted knife wounds
Excerpted